University of Missouri researchers have developed a test that can detect Rocky Mountain spotted fever in about 40 minutes.

Abbott’s valuation debate sharpens as legal pressure eases and medical devices, diagnostics, earnings quality, and future cash generation support its outlook.

A new method at the University of Missouri could transform how Rocky Mountain spotted fever is diagnosed. The method detects ...

Abbott Laboratories gains attention as medical devices, diabetes care, cardiovascular products, and raised guidance ...

Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.

Rapid advancements in Chinese artificial intelligence models raise more questions about costly technology spending, as Google ...

Despite the inaccurate early test results, federal health officials said they remain focused on lettuce from Taylor Farms as ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Abbott Laboratories' strength in Medical Devices business and the recently acquired Exact Sciences should keep driving growth ...

(RTTNews) - Shares of Abbott Laboratories were gaining around 11 percent in the early morning trading on the NYE, after the medical devices and ...

Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street Abbott Laboratories (NYSE:ABT) reported second-quarter ...

Second-quarter reported sales growth of 13.0 percent; comparable sales growth of 4.8 percent Second-quarter GAAP diluted EPS of $0.53; adjusted diluted EPS of $1.31 ...